China
· Delayed Price · Currency is CNY Shenzhen Kangtai Biological Products Statistics
Total Valuation
Shenzhen Kangtai Biological Products has a market cap or net worth of CNY 21.37 billion. The enterprise value is 23.17 billion.
| Market Cap | 21.37B |
| Enterprise Value | 23.17B |
Important Dates
The last earnings date was Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 14, 2024 |
Share Statistics
Shenzhen Kangtai Biological Products has 1.12 billion shares outstanding. The number of shares has decreased by -14.89% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.12B |
| Shares Change (YoY) | -14.89% |
| Shares Change (QoQ) | +6.24% |
| Owned by Insiders (%) | 47.33% |
| Owned by Institutions (%) | 8.59% |
| Float | 588.30M |
Valuation Ratios
The trailing PE ratio is 41.75 and the forward PE ratio is 20.13. Shenzhen Kangtai Biological Products's PEG ratio is 0.52.
| PE Ratio | 41.75 |
| Forward PE | 20.13 |
| PS Ratio | 7.10 |
| PB Ratio | 2.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 283.84 |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 41.29, with an EV/FCF ratio of 307.83.
| EV / Earnings | 44.96 |
| EV / Sales | 7.64 |
| EV / EBITDA | 41.29 |
| EV / EBIT | 62.61 |
| EV / FCF | 307.83 |
Financial Position
The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.23 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 3.77 |
| Debt / FCF | 28.12 |
| Interest Coverage | 3.01 |
Financial Efficiency
Return on equity (ROE) is 5.34% and return on invested capital (ROIC) is 1.94%.
| Return on Equity (ROE) | 5.34% |
| Return on Assets (ROA) | 1.58% |
| Return on Capital (ROIC) | 1.94% |
| Revenue Per Employee | 1.59M |
| Profits Per Employee | 270,951 |
| Employee Count | 1,902 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 0.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.38% in the last 52 weeks. The beta is 0.93, so Shenzhen Kangtai Biological Products's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -36.38% |
| 50-Day Moving Average | 17.06 |
| 200-Day Moving Average | 18.73 |
| Relative Strength Index (RSI) | 52.23 |
| Average Volume (20 Days) | 21,761,247 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shenzhen Kangtai Biological Products had revenue of CNY 3.03 billion and earned 515.35 million in profits. Earnings per share was 0.46.
| Revenue | 3.03B |
| Gross Profit | 2.39B |
| Operating Income | 370.08M |
| Pretax Income | 509.78M |
| Net Income | 515.35M |
| EBITDA | 561.22M |
| EBIT | 370.08M |
| Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 310.71 million in cash and 2.12 billion in debt, giving a net cash position of -1.81 billion or -1.62 per share.
| Cash & Cash Equivalents | 310.71M |
| Total Debt | 2.12B |
| Net Cash | -1.81B |
| Net Cash Per Share | -1.62 |
| Equity (Book Value) | 9.71B |
| Book Value Per Share | 8.69 |
| Working Capital | 3.23B |
Cash Flow
In the last 12 months, operating cash flow was 643.54 million and capital expenditures -568.26 million, giving a free cash flow of 75.28 million.
| Operating Cash Flow | 643.54M |
| Capital Expenditures | -568.26M |
| Free Cash Flow | 75.28M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 78.70%, with operating and profit margins of 12.21% and 17.00%.
| Gross Margin | 78.70% |
| Operating Margin | 12.21% |
| Pretax Margin | 16.82% |
| Profit Margin | 17.00% |
| EBITDA Margin | 18.51% |
| EBIT Margin | 12.21% |
| FCF Margin | 2.48% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 2.03%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 2.03% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 89.49% |
| Buyback Yield | 14.89% |
| Shareholder Yield | 16.92% |
| Earnings Yield | 2.40% |
| FCF Yield | 0.35% |
Stock Splits
The last stock split was on June 2, 2022. It was a forward split with a ratio of 1.6.
| Last Split Date | Jun 2, 2022 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
Shenzhen Kangtai Biological Products has an Altman Z-Score of 3.85.
| Altman Z-Score | 3.85 |
| Piotroski F-Score | n/a |